197 related articles for article (PubMed ID: 30867802)
1. Inhibition of phosphodiesterase 4D decreases the malignant properties of DLD-1 colorectal cancer cells by repressing the AKT/mTOR/Myc signaling pathway.
Kim DU; Nam J; Cha MD; Kim SW
Oncol Lett; 2019 Mar; 17(3):3589-3598. PubMed ID: 30867802
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.
Kim DU; Kwak B; Kim SW
Biochem Biophys Res Commun; 2019 Jan; 508(3):825-831. PubMed ID: 30528730
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
[TBL] [Abstract][Full Text] [Related]
4. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
Nummela P; Zafar S; Veikkolainen E; Ukkola I; Cinella V; Ayo A; Asghar MY; Välimäki N; Törnquist K; Karhu A; Laakkonen P; Aaltonen LA; Ristimäki A
Int J Cancer; 2024 Jun; 154(11):1987-1998. PubMed ID: 38319157
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells.
Tong L; Shan M; Zou W; Liu X; Felsher DW; Wang J
Front Oncol; 2022; 12():904969. PubMed ID: 35978822
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition.
Zhu X; Li W; Li Y; Xu W; Yuan Y; Zheng V; Zhang H; O'Donnell JM; Xu Y; Yin X
Neuropharmacology; 2019 Jul; 153():20-31. PubMed ID: 31026437
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
Kwak B; Kim DU; Kim TO; Kim HS; Kim SW
Int J Oncol; 2018 Oct; 53(4):1800-1808. PubMed ID: 30066856
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.
Kaname T; Ki CS; Niikawa N; Baillie GS; Day JP; Yamamura K; Ohta T; Nishimura G; Mastuura N; Kim OH; Sohn YB; Kim HW; Cho SY; Ko AR; Lee JY; Kim HW; Ryu SH; Rhee H; Yang KS; Joo K; Lee J; Kim CH; Cho KH; Kim D; Yanagi K; Naritomi K; Yoshiura K; Kondoh T; Nii E; Tonoki H; Houslay MD; Jin DK
Cell Signal; 2014 Nov; 26(11):2446-59. PubMed ID: 25064455
[TBL] [Abstract][Full Text] [Related]
9. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway.
Huang P; Wei S; Luo M; Tang Z; Lin Q; Wang X; Luo M; He Y; Wang C; Wei D; Xia C; Xu J
Ann Transl Med; 2021 Oct; 9(20):1594. PubMed ID: 34790800
[TBL] [Abstract][Full Text] [Related]
11. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
12. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
13. PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner.
Cao M; Nawalaniec K; Ajay AK; Luo Y; Moench R; Jin Y; Xiao S; Hsiao LL; Waaga-Gasser AM
Transl Oncol; 2022 May; 19():101377. PubMed ID: 35196602
[TBL] [Abstract][Full Text] [Related]
14. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
Jeong MH; Urquhart G; Lewis C; Chi Z; Jewell JL
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427586
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.
Mishra RR; Belder N; Ansari SA; Kayhan M; Bal H; Raza U; Ersan PG; Tokat ÜM; Eyüpoğlu E; Saatci Ö; Jandaghi P; Wiemann S; Üner A; Cekic C; Riazalhosseini Y; Şahin Ö
Clin Cancer Res; 2018 Apr; 24(8):1987-2001. PubMed ID: 29386221
[No Abstract] [Full Text] [Related]
17. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D.
Qiang Z; Zhou ZY; Peng T; Jiang PZ; Shi N; Njoya EM; Azimova B; Liu WL; Chen WH; Zhang GL; Wang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):288. PubMed ID: 30482227
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
[TBL] [Abstract][Full Text] [Related]
20. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]